Eris Lifesciences Limited (NSEI:ERIS) agreed to acquire 51% stake in Swiss Parenterals Limited for INR 6.4 billion on February 13, 2024. The deal has been approved by board of directors of Eris Lifesciences Limited. Shardul Amarchand Mangaldas & Co led by Nivedita Tiwari, Devesh Pandey, Shilpa Mankar Ahluwalia, Shubhangi Garg, Gouri Puri, Ritwik Bhattacharya, acted as legal advisor to Eris Lifesciences Limited and Swiss Parenterals Limited for the acquisition.

Eris Lifesciences Limited (NSEI:ERIS) completed the acquisition of 51% stake in Swiss Parenterals Limited on February 15, 2024. Ravi Shah of Cyril Amarchand Mangaldas acted as due diligence provider to Swiss Parenterals.